loader image
Welcome to the Centre for Bioregulatory Medicine

This article will cover information on Prolotherapy including general questions on Prolotherapy treatments, side effects, research, reviews, and medical studies.

Prolotherapy has been utilized in clinical practices for over 80 years. Standardized and reviewed in clinical application by Dr. George Hackett in the 1950s, prolotherapy has been shown to be an effective treatment in patients who suffer from joint instability due to ligament damage and overuse and related musculoskeletal and osteoarthritis.

Prolotherapy’s popularity as a treatment for chronic pain has intensified over the past two decades among both physicians and patients as clinical and anecdotal observations has proved in many cases its reliance as a non-surgical option for joint and back pain.

The discussion subjects of this article on Prolotherapy reviews and research examinations:

  • What is Prolotherapy?
  • Is Prolotherapy like cortisone?
  • Prolotherapy treatments goals.
  • What are in Prolotherapy injections?
  • Platelet Rich Plasma Therapy and PRP Prolotherapy.
  • What is the evidence for Prolotherapy?
  • Prolotherapy for knee pain.
    • Knee osteoarthritis.
      • Prolotherapy research on rebuilding cartilage in knees.
      • Ozone Prolotherapy for knee osteoarthritis.
      • Prolotherapy compared to PRP in the treatment of knee osteoarthritis.
    • Osgood-Schlatter disease.
    • Chronic Patellar tendinopathy
    • Prolotherapy for sports related knee ligament injuries.
      • Prolotherapy for an ACL tear
  • Prolotherapy for Back Pain.
    • Lumbar instability as an etiology of low back pain and its treatment by Prolotherapy.
    • Prolotherapy for patients with long-term and often severe low back pain and disability having failed physical therapy and chiropractic.
    • Prolotherapy for failed back surgery syndrome.
    • Sacroiliac joint-mediated pain
  • Prolotherapy for shoulder pain.
    • Glenoid labrum tears
  • Prolotherapy for Cervical Spine Instability and related symptoms.
  • Prolotherapy and Whiplash Associated Disorders.
  • Prolotherapy for hip pain.
  • Prolotherapy for TMJ.
  • Prolotherapy for Elbow Pain.
  • Prolotherapy for chronic plantar fasciitis.
    • Comparing Prolotherapy to cortisone for chronic plantar fasciitis
    • Comparing Prolotherapy to extracorporeal shockwave therapy (ESWT).
  • Prolotherapy for myofascial pain syndrome
  • Pricing & Prices for Consultations and Treatments

What is Prolotherapy?

Prolotherapy is a nonsurgical regenerative injection technique that introduces small amounts of an irritant solution to the site of painful and degenerated tendon insertions (entheses), joints, ligaments, and in adjacent joint spaces during several treatment sessions to promote growth of normal cells and tissues.

Irritant solutions most often contain dextrose (d-glucose), a natural form of glucose normally found in the body, but may also contain combinations of polidocanol, manganese, zinc, pumice, ozone, glycerin, or phenol.

In severe cases, autologous cellular solutions may also be needed, such as platelet-rich plasma (PRP), bone marrow, or adipose tissue.

For the patient, the goal of Prolotherapy in chronic musculoskeletal pain and instability is the stimulation of body’s natural healing and regenerative processes in the joint that will facilitate the repair and regrowth of connective tissue, ligaments, tendons for tensile strength, and cartilage and other joint stabilizing structures such as labral tissue.

Prolotherapy works by the same process that the human body naturally uses to stimulate the body’s healing system, a process called inflammation. The technique involves the injection of a proliferant (a mild irritant solution) that causes an inflammatory response which “turns on” the healing process. The growth of new ligament and tendon tissue is then stimulated. The ligaments and tendons produced after Prolotherapy appear much the same as normal tissues, except that they are thicker, stronger, and contain fibers of varying thickness, testifying to the new and ongoing creation of tissue. This is documented in the research below.

Learning points

  • Prolotherapy is an in-office injection treatment that research and medical studies have shown to be an effective, trustworthy, reliable alternative to surgical and non-effective conservative care treatments.
  • In our opinion, based on extensive research and clinical results, Prolotherapy can be superior to many other treatments in relieving the problems of chronic joint and spine pain and, most importantly, in getting people back to a happy and active lifestyle.

Is Prolotherapy like cortisone? 

  • The difference between Prolotherapy and Cortisone is extensive.
  • Cortisone when injected into the joint can successfully mask pain. Many people have very successful treatments with Cortisone. We typically see patients who have a long history of Cortisone injection and these injections are no longer effective for them.
  • Cortisone has been shown, in many studies, to accelerate degenerative osteoarthritis through cartilage breakdown.
  • Over the years we have seen many patients who have received corticosteroid (cortisone) injections for joint pain. Unfortunately for many, excessive cortisone treatments lead to a worsening of chronic pain. Again, while some people do benefit from cortisone in the short-term – the evidence however points to cortisone causing more problems than it helps.

Prolotherapy is a regenerative injection treatment used to treat joint and spine pain by repairing damaged and weakened ligaments and tendons.

  • Prolotherapy is considered a viable alternative to surgery, and as an option to pain medications, cortisone and other steroidal injections.
  • The Prolotherapy procedure is considered a safe, affordable option that allows the patient to keep working and/or training during treatment.

Principle findings reveal that dextrose prolotherapy has a clear and positive effect on chronic musculoskeletal pain ranging from 6 months to 1 year.

A December 2020 study in the journal Anesthesia and Pain Medicine (1) made these observations on prolotherapy treatment:

  • The researchers principle findings revealed that dextrose prolotherapy has a clear and positive effect on chronic musculoskeletal pain ranging from 6 months to 1 year.
  • In comparison with saline injection or exercise, treatment with prolotherapy showed a moderately superior therapeutic effect. In particular, prolotherapy was found to be more effective than exercise from one month after treatment.
  • Prolotherapy was also found to have a similar effect to steroids or PRP (Platelet Rich Plasma injections) one month after treatment.
  • In a comparison of the effects of corticosteroid injection and prolotherapy in patients with first carpometacarpal (thumb) osteoarthritis, one study reported that the corticosteroid injection group had better results of pain score at 1 month. However, after 2 months, prolotherapy had a more favorable outcome than corticosteroid injection. Another concern of corticosteroids is adverse effects, in contrast, prolotherapy has no serious side effects and is effective, safe, and sustainable.
  • In conclusion, dextrose-based prolotherapy has been shown to have a positive and significantly beneficial effect for patients with chronic musculoskeletal pain, ranging from 6 months to 1 year. There is evidence that dextrose-based prolotherapy has a better therapeutic effect than exercise, and that it has a similar effect compared to PRP and steroid injection.

Prolotherapy Treatment Goals.

What are the goals of Prolotherapy treatments?

  • Function Is the patient’s ability to function in activities of daily living improved? Is the patient able to perform previously painful activities without pain? Is the person able to do things that he/she could not do prior to Prolotherapy? Patients are typically advised to continue to receive Prolotherapy treatments until able to stably perform that certain function pain and cracking-free. For example, if a patient can now climb two flights of stairs without knee pain after Prolotherapy, whereas prior to the Prolotherapy this would cause excruciating pain, then we know that Prolotherapy is helping improve function.
  • Strength Ligament and tendon injury may cause muscle strength to decline. When a person receives Prolotherapy, one of the noticeable effects of the treatment is that strength improves in the injected areas.
  • Pain Pain is one of the most common reasons patients receive Prolotherapy. Thus, a noticeable decrease in pain shows the  benefit of successful Prolotherapy.
  • Stiffness Patients commonly experience stiffness upon morning rising or after performing a certain activity. This stiffness is commonly felt in the lower back or neck, but could involve any area of the body. A great sign that Prolotherapy is working is that stiffness has subsided. Once Prolotherapy helps stabilize the area involved, the muscles no longer have to provide this stability so they relax. Once they relax, the stiffness subsides.
  • Physical Examination An experienced Prolotherapy doctor should be able to assess whether the Prolotherapy is working by simple physical examination. The physician can also listen for crepitation or crunching in the joints which can often be audibly heard by moving the joint. The joint that doesn’t crunch is also improving. X-rays and MRIs are poor indicators that Prolotherapy is working, the reason being that most ligaments do not show up well on these tests. Some improvements from Prolotherapy can be seen with x-rays and MRI’s, but it isn’t always necessary or advantageous to rely solely on those indicators due to their high incidence of inaccuracies.

What are in Prolotherapy injections?

The primary ingredient in Prolotherapy injections used at the Centre is dextrose. How does dextrose accelerate healing?

This technique involves using the simple and safe base solution dextrose as the primary proliferant, along with an anesthetic (such as procaine or lidocaine), that is given into and around the entire painful/injured area(s). Many injections are given during each treatment, versus just a few injections. Most treatments are provided every 4 to 6 weeks to allow time for the growth of new connective tissues.

In these basic Prolotherapy injection solutions, we also use an alkaline extract of the pitcher plant called Sarapin. Almost all pain issues have some kind of nerve component, which Sarapin helps to relieve. In our experience, Sarapin enhances the healing effects of injection treatments and has an excellent safety profile. It is one of the few materials found in the Physicians’ Desk Reference that has no known side effect. Also in the basic solution, to help ease the pain of the injection procedure, as well as provide pain relief to the area, procaine or lidocaine is added in very small quantities. Often, this helps to ease the pain right away after the procedure, but is used in such a small amount to not cause any adverse effect to the joint repair/wound healing cascade.

With a comprehensive approach, we utilize many different types of Prolotherapy solutions, individualizing each treatment according to the patients’ unique needs. The solutions are changed depending on the individual patient and the amount of inflammatory reaction required to produce sufficient healing and new collagen growth. We also use cellular proliferants such as blood, PRP (platelet rich plasma), bone marrow, and stem cells.

As with other medical procedures, Prolotherapy is a specialty. If you are looking into Prolotherapy, you first want to make sure that the Prolotherapy doctor or Prolotherapist experienced in the Comprehensive Prolotherapy procedure and has successfully treated cases like yours.

PRP and PRP Prolotherapy

  • PRP stands for Platelet Rich Plasma Therapy.
  • The treatment takes your blood, like going for a blood test, and re-introduces the concentrated blood platelets from your blood into areas of chronic joint and spine deterioration.
  • Your blood platelets contain growth and healing factors. When concentrated through simple centrifuging, your blood plasma becomes “rich” in healing factors, thus the name Platelet RICH plasma. Platelets play a central role in blood clotting and wound/injury healing.
  • The procedure and preparation of therapeutic doses of growth factors consist of an autologous blood collection (blood from the patient), plasma separation (blood is centrifuged), and application of the plasma rich in growth factors (injecting the plasma into the area.) In our office, patients are generally seen every 4-6 weeks. Typically three to six visits are necessary per area.

A January 2021 study in the journal Anesthesia and pain medicine (2) “found that PRP and dextrose prolotherapy were shown to be effective for treating degenerative conditions and injuries. Both PRP therapy and prolotherapy commonly have regenerative therapeutic properties, but the central mechanisms of prolotherapy and PRP are different.

In prolotherapy, hyperosmolar dextrose triggers an inflammatory response, increases platelet-derived growth factor expression, and upregulates several mitogenic factors that may act as signaling mechanisms in tendon repair. In PRP therapy, it aims to augment the natural healing process of tendon repair and regeneration by delivering high concentrations of growth factors directly to a lesion.”

In other words, Prolotherapy does not act directly as a patch on a tear but rather is initiates a new and natural healing response to injury. PRP does act in a “patch-like” method to repair a tear. It is this understanding of these two treatments which leads us to use both treatments to help the patients.

What type of treatment do I need?

A major factor in determining which treatment to get is the extent of your injury and whether this is a recent injury or a problem with degenerative joint disease or degenerative arthritis.

  • General patient type 1: Younger patient, athlete, active, or with a physically demanding job. Recent injury, such as a sprain that has not healed all the way.
    • Injury is still causing pain and discomfort.
    • This is the type of injury that does very well with dextrose Prolotherapy injections.
    • Dextrose is a sugar water that when injected into the injured joint attracts you own healing repair cells into the area to fix damaged soft tissue such as ligaments and tendons.
  • General patient type 2: Chronic problems from an “old” injury, such as a sprain that happened a few years ago,
    • Injury “never really healed,” has progressively worsened. Causing pain, discomfort.
    • Injury has not responded long-term to more conservative care options such as NSAIDs, medications, cortisone, physical therapy
    • Soft tissue damage continues, joint instability has become more permanent.
    • In this patient, it may not be enough to attract your own cells to this damaged area with Prolotherapy, in this type case we may have to put cells there by injection. Our first option would be Platelet Rich Plasma Therapy (PRP). This would put the healing factors found in your blood platelets into the damaged joint.
    • WE DO NOT offer PRP as a stand-alone treatment or injection. While PRP brings healing cells into the joint, it acts to repair degenerative damage. In our experience, while PRP addresses damage deep in the joint, we must still address the joint instability problem created around the joint. We do this with Prolotherapy. Here damaged or weakened ligaments that are simply “stretched,” can be strengthened with treatment to help restore and maintain normal joint mobility.
    • Simple PRP on the inside, Prolotherapy on the outside of the joint.
  • General patient type 3: Chronic long-term degenerative problems. Possibly in need of a joint replacement
    • This is a patient who may have had degenerative joint disease for many years even decades. These are the “bone on bone people.” They have exhausted all means of conservative care, they may have had short-term success with PRP treatments, hyaluronic acid treatments, cortisone injections, but none of these are helpful anymore.
    • It is important to realize and it will be explained in this article, that it is rare that we would need to go to stem cell therapy in many of these patients. When we do recommend stem cells it would be from your own stem cell sources and mostly taken from bone marrow. We do not offer “stem cell therapy,” from donated source material.

What is the evidence for Prolotherapy?

For patients who are looking into Prolotherapy, please understand that this is a specialty procedure with technique and experience being a key component. What we present on our website is based on our experience and research and does not apply to all practitioners or injection therapies.

In July 2016, doctors published findings on the effectiveness of Prolotherapy treatments in the medical journal: Clinical Insights: Arthritis and Musculoskeletal Disorders, (3) here are the summary highlights:

Our doctors reviewed 32 studies on dextrose prolotherapy for chronic musculoskeletal pain. The following conclusions are made:

Overall, Prolotherapy has been demonstrated to be efficacious and should be considered as a treatment for pain and dysfunction associated with chronic musculoskeletal conditions, particularly tendinopathies and osteoarthritis.


 

Demonstration of Knee Prolotherapy

In this video the patient is being prepared and treated by dextrose prolotherapy for instability of the inner (medial) ligament, medial meniscus and anterior/posterior cruciate ligaments.

He complained of knee pain on the inside of the knee, pain behind the kneecap and noises in the knee when walking up and down stairs.

Two prolotherapy treatments and an osteopathic manipulation resolved the condition.

Published research papers  on Knee Disorders.

Recent Prolotherapy knee research

Prolotherapy for Knee Osteoarthritis

A June 2022 study in the journal Clinical rehabilitation (70) “assessed the effectiveness, compliance, and safety of dextrose prolotherapy for patients with knee osteoarthritis.” Researchers gathered data from 14 previously published studies with a combined 978 patients. The researchers found: “Compared with placebo injection and noninvasive control therapy, dextrose prolotherapy had favorable effects on pain, global function, and quality of life during the overall follow-up. Dextrose prolotherapy yielded greater reductions in pain score over each follow-up duration than did the placebo. Compared with other invasive therapies, dextrose prolotherapy generally achieved comparable effects on pain and functional outcomes for each follow-up duration.”

Led by researchers at the University of California at Los Angeles (UCLA) and the Department of Biological Sciences, at the University of Southern California (USC) a June 2021 paper in the medical journal Cartilage (4) offered these observations:

“Hypertonic dextrose injections (prolotherapy) for osteoarthritis are reported to (be able to) reduce pain. Cartilage regeneration is hypothesized as a mechanism. This in vitro study identifies a Prolotherapy concentration that stimulates chondrogenic cells to increase metabolic activity and assesses whether this concentration affects collagen deposition and proliferation.”

What the researchers are doing is taking hypertonic dextrose (a concentrate simple sugar, the main ingredient in the Prolotherapy solution) to see if, in a lab setting, they can grow cartilage cells with it. This was their observation.

(Prolotherapy)  “solution appears to be associated with the increased metabolic activity of chondrocytes (reproduction of the cells that make cartilage), increased collagen deposition, and increased chondrocyte proliferation. These results support clinical prolotherapy research suggesting that intra-articular Hypertonic dextrose joint injections reduce knee pain. Further study of Hypertonic dextrose injections and cellular processes is warranted.”

A May 2020 study in the Annals of Family Medicine (5) made this simple statement at the conclusion of the research findings:

  • “Intra-articular dextrose prolotherapy injections reduced pain, improved function and quality of life in patients with knee osteoarthritis compared with blinded saline injections. The procedure is straightforward and safe; the adherence and satisfaction were high.”

Another study from May 2020 published in The Journal of Alternative and Complementary Medicine (6) made these observations:

  • “These findings suggest that dextrose prolotherapy is effective at reducing pain and improving the functional status and quality of life in patients with knee osteoarthritis.

In January 2019, David Rabago, MD, of the University of Wisconsin School of Medicine and Public Health, published research on Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis in the Journal of Alternative and Complementary Medicine. (7) The study concluded:

  • “(suggested) that Prolotherapy in this primary care clinic is feasible and acceptable.” In other words, it is beneficial to patients.

May increase joint space

A January 2022 study (17) found that knee osteoarthritis patients receiving hypertonic dextrose prolotherapy had improvement of knee pain, stiffness, and function and increasing tendency in the medial minimum joint space width.

Compared to hyaluronic acid

A November 2021 study (18) found: “(Prolotherapy) appears to be an effective intervention to decrease pain and improve function in knee osteoarthritis, with efficacy similar to intra-articular injections with hyaluronic acid in the short-term follow-up.”

Prolotherapy treatment significantly improved total pain and knee function compared with control groups.

An August 2021 study in the journal Aging Clinical and Experimental Research (20) reviewed and analyzed Prolotherapy injections for the treatment of knee osteoarthritis. Their findings were that at an average 23 weeks follow-up, Prolotherapy treatment significantly improved total pain and knee function compared with control groups. There were no severe adverse events related to dextrose injection reported in all the included studies. Prolotherapy is a promising treatment for knee osteoarthritis with a reasonable safety profile.

Dextrose prolotherapy may be considered in knee osteoarthritis

A May 2021 study in the Journal of Clinical Orthopaedics and Trauma (8) wrote: “Prolotherapy in knee osteoarthritis confers potential benefits for pain but the studies are at high risk of bias. Based on two well-designed studies, dextrose Prolotherapy may be considered in knee osteoarthritis (strength of recommendation B). This treatment is safe and may be considered in patients with limited alternative options (strength of recommendation C).”

Basically, Prolotherapy appears to be helpful, it would be better if these researchers had more research to review.

Prolotherapy for knee pain patients not responding to conventional care

A May 2020 study in The Journal of Alternative and Complementary Medicine (27) of 66 patients aged 40–70 years with chronic knee pain that was not responding to conservative therapy and diagnosed as grade II or III knee osteoarthritis were divided into three different groups, 22 patients received dextrose Prolotherapy, 22 patients received saline injections, and 22 patients received were used as a control group.

  • The intra- (inside the knee) and extra-articular (around the knee) dextrose Prolotherapy and saline injections were administered at 0, 3, and 6 weeks. A home-based exercise program was prescribed for all patients in all three groups.
  • Disability and pain scores improved significantly in the dextrose Prolotherapy group compared to the saline group and control group at 18 weeks. Stiffness scores decreased in the dextrose Prolotherapy group compared to the control group at 18 weeks. Physical functioning scores were improved in the dextrose Prolotherapy group compared to the control group at 18 weeks. The physical component scores of “quality of life” were significantly improved in the dextrose Prolotherapy group compared to the control group at 18 weeks.
  • These findings suggest that dextrose Prolotherapy is effective at reducing pain and improving the functional status and quality of life in patients with knee osteoarthritis.

Prolotherapy injections in and around the knee

Doctors writing in the Journal of Pain Research (54) found that patients who received Prolotherapy with dextrose periarticular injections around the knee joint with patients who received Prolotherapy intra-articular injections. In other words, one group received injections around the knee joint, another group received injections directly into the knee joint.

  • Both peri- and intra-articular Prolotherapy patients showed reduced pain and disability of their knee osteoarthritis after 5 months of follow-up.
  • Interestingly, periarticular Prolotherapy had better effects on pain scores and disability scores in some respects.
    • Periarticular Prolotherapy injections showed superior effects on healing of knee disability and pain score compared with intra-articular injections. This would indicate total knee instability and not an isolated injury.

Prolotherapy rebuilds and protects cartilage in the knees

A December 2021 paper in the journal Cartilage (23) tested the idea that Prolotherapy can reduce knee pain by growing cartilage. This was a laboratory experience to see if a dextrose solution similar to that used in Prolotherapy, could grow cartilage in a laboratory setting. The researchers found: “(Dextrose) appears to be associated with the increased metabolic activity of chondrocytes, increased collagen deposition, and increased chondrocyte proliferation. These results support clinical Prolotherapy research suggesting that intra-articular (dextrose) joint injections reduce knee pain.

A May 2021 paper in the Journal of Rehabilitation Medicine (25) found: “Dextrose Prolotherapy is an alternative injection therapy for knee osteoarthritis, which was found to be associated with a significant reduction in urinary C-terminal telopeptide of type II collagen compared with hyaluronic acid injection.” Higher urinary C-terminal telopeptides of type II collagen are seen as markers of cartilage breakdown that occurs in early cartilage degradation.

A 2015 study published in the journal Therapeutic Advances in Musculoskeletal Disease (61) described Prolotherapy’s ability to rebuild soft tissue and cartilage. 

  • “Prolotherapy has been reported as a useful method in the treatment of chronic musculoskeletal and joint diseases. It is proposed that Prolotherapy causes mild inflammation and cell stress in the weakened ligament or tendon area, releases cytokines and growth factors, and induces a new healing cascade in that area, which leads to activation of fibroblasts, generation of collagen precursors, and strengthening of the connective tissue.”

Ozone Prolotherapy for knee osteoarthritis 

An August 2021 study (21) in the journal Evidence-Based Complementary and Alternative Medicine compared the effect of hypertonic saline with ozone plus hypertonic saline in improving the symptoms of osteoarthritis in the patients. The results showed that intra-articular prolozone therapy and hypertonic saline injection can lead to improvement of pain and function in patients with knee osteoarthritis at the same status without any significant difference. Note that dextrose was replaced with saline.

A November 2020 study in the journal Anesthesiology and Pain Medicine (22) wrote that “for patients with knee osteoarthritis, Prolotherapy with ozone plus hypertonic dextrose and somatropin was more effective in sedating the pain and improving the stiffness and function of the knee than dextrose and somatropin alone.”

Prolotherapy compared to PRP in the treatment of knee osteoarthritis

Results of the present study suggested a significant decrease in the overall WOMAC score of patients who undergo either PRP therapy or PRL. This positive change in the overall WOMAC score led to an improvement in the quality of life of patients with knee OA shortly after the first injection. PRP injection is more effective than PRL in the treatment of knee OA.

A January 2018 study in the Clinical Interventions in Aging (26) when comparing Prolotherapy to PRP injections “suggested a significant decrease in the overall (pain and disability) score of patients who undergo either PRP therapy or Prolotherapy. This positive change in the overall (pain and disability) score led to an improvement in the quality of life of patients with knee osteoarthritis shortly after the first injection. PRP injection is more effective than Prolotherapy in the treatment of knee osteoarthritis.”

August 2019 in the journal Advances in Rheumatology (28) wrote: “In terms of pain reduction and function improvement, Prolotherapy with hypertonic dextrose was more effective than (injections of) local anesthetics, as effective as (injections of) hyaluronic acid, ozone or (treatment of) radiofrequency and less effective than PRP and erythropoietin (hormone protein that stimulates red blood production), with a beneficial effect in the short, medium and long term. In addition, no side effects or serious adverse reactions were reported in patients treated with hypertonic dextrose. Although hypertonic dextrose Prolotherapy seems to be a promising interventional treatment for knee osteoarthritis, more studies with better methodological quality and low risk of bias are needed to confirm the efficacy and safety of this intervention.”

Prolotherapy for sports-related knee ligament injuries

Prolotherapy for an ACL tear

In 2009, Prolotherapy doctors led by Walter Grote MD published a case history of an 18-year old female patient who returned to sports after a high-grade partial (possibly complete) ACL rupture.

This case report, published in the medical journal International Musculoskeletal Medicine, documented the successful non-surgical repair of an MRI-confirmed high grade or total ACL tear in an 18-year-old female with knee laxity and instability using Prolotherapy and at-home exercise. After treatment, the patient regained full knee function, resumed normal activity, and returned to recreational sport. Post-treatment MRI revealed a healing chronic ACL tear. These findings are notable given that surgical ACL reconstruction is the conventional treatment for ACL tears with such clinical presentation.

As exciting as this sounds, Dr. Grote and colleagues noted that there were too many factors in this ACL healing to confirm it was caused by Prolotherapy treatment alone. They questioned first of all was the MRI of a complete ACL rupture even accurate? (68)

24-year-old soccer player with knee instability

A case study was reported in the American Journal of Physical Medicine & Rehabilitation in April 2020. (67) A 24-yr-old male soccer player with a seven-year history of left posterior knee “looseness” came in for examination. At the time of initial injury, the patient suffered from atraumatic anterior and posterior cruciate ligament sprains. Seven years the patient now described knee pain as a constant, dull ache, a 3 out of ten pain. His biggest complaint however was this feeling of “instability” and looseness where his knee would “buckle” 3-4 times a week.

Physical examination was positive for grade 1 posterior drawer and grade 1 posterior sag signs (signs of a partial tear).  The sonographic evaluation confirmed magnetic resonance imaging findings of posterior cruciate ligament laxity and buckling and a small cystic lesion pressing against the posterior cruciate ligament.  After a trial of physical therapy, the patient received dextrose hyperosmolar (Prolotherapy) solution. This resulted in the resolution of the cyst and the patient’s subjective feeling of looseness and instability was resolved by seven weeks.

In 2003, K. Dean Reeves, MD published his findings of the effect of Prolotherapy on ACL tears in the Alternative Therapies in Health and Medicine (69)

Study Summary:

  • Simple dextrose Prolotherapy injections used in 16 knees with a loose ACL ligament
    • At the 3-year follow-up pain with walking had improved by 43%, subjective swelling improved 63%, flexion range of motion improved by 10.5 degrees, and machine measure of ACL ligament looseness improved by 71%.
    • 10/16 knees were no longer loose by machine measurement at the time of follow-up, and symptoms were improved.
    • A symptom of osteoarthritis improved even in those who still tested loose.
    •  

Prolotherapy for Osgood-Schlatter disease

An October 2021 study in the Archives of Orthopaedic and Trauma Surgery (19) compared Prolotherapy to saline placebo. “After three injections, at the 6-month and 12-month follow-up visits, the (pain and function) scores of the two groups were significantly improved; the dextrose group score was better than the saline group score, and there were significant differences between the two groups.”

Prolotherapy for Chronic Patellar tendinopathy

A November 2020 study in the Journal of Experimental Orthopaedics (49) examined the use of Prolotherapy and Sclerotherapy injections. A note of understanding. At one time Prolotherapy and Sclerotherapy were used as somewhat synonymous terms. They are however not the same treatment. Prolotherapy injections center on the joints with the repair of the tendon, ligaments, and cartilage. Sclerotherapy focuses on the blood vessels and is considered a treatment for varicose veins. The findings: The researchers examined ten previously published papers and found positive results with an increase in functional ability scores and decreases in pain scores in the patients examined. “Among all ten studies, no serious adverse events were reported. Based on this limited set of studies, there seems to be some evidence that Sclerotherapy and Prolotherapy may be effective treatment options to treat pain and to improve function in patients with Chronic Patellar tendinopathy.”

Prolotherapy for Back Pain

Published research papers  on low back pain

Lumbar instability as an etiology of low back pain and its treatment by prolotherapy

In December 2021, our peer review paper Lumbar instability as an etiology of low back pain and its treatment by Prolotherapy: A review was published in the Journal of Back and Musculoskeletal Rehabilitation (29) was published. For the full version or abbreviated lay version please see our article Prolotherapy treatments for lumbar instability and low back pain.

The main theme of this article is treating low back pain with Prolotherapy. These are some of the previously published papers we used as source information.

  • Although facet joint pain can account for up to 45% of low back pain, there are few randomized controlled studies in the literature on the use of comprehensive or cellular prolotherapy for treating this type of pain. Narrative review studies (where the authors interpret previously published medical works) and systemic reviews (where the authors combine data and empirical evidence from previously published medical works), as well as meta-analysis (authors rely on data outcomes), noted overall positive results, especially with cellular (PRP and/or Mesenchymal stem cells prolotherapy but mixed with dextrose prolotherapy for chronic low back pain.

Research:

  • A single-blind, randomized, crossover study (30) evaluated the effectiveness of injection therapy in 35 patients diagnosed as having painful enthesopathies (these are painful conditions caused by the ligament or tendon attachment to the bone).
    • In this study, 86% of patients had prior spinal surgery and continued pain.
    •  Thirty-five patients diagnosed as having painful enthesopathies as a major pain generator were studied.
    • Among the study’s participants, 86% had undergone prior spinal surgery, and all had been referred to a neurosurgeon to see if more surgery was needed.
    • Patients were injected with either anesthetic alone or with anesthetics combined with a phenol-glycerol proliferant (Prolotherapy).
  • Clinical assessment revealed 80% of patients had excellent to good relief of pain and tenderness when Prolotherapy injections were given, but only 47% of patients given anesthetics alone had the same amount of pain relief.
  • Of the questionnaire responses, 66% reported excellent to good pain relief after Prolotherapy vs. 34% after anesthetics alone.

Research:

Sustained pain reduction has been demonstrated in a prospective consecutive patient series in which the effects of disc space injections of hypertonic dextrose were assessed in patients with chronic advanced degenerative discogenic leg pain, with or without low back pain, including those with moderate to severe disc degeneration. In this 2006 study published in the journal, Pain Medicine patients underwent bi-weekly disc space injections of a solution consisting of 50% dextrose and 0.25% bupivacaine in the affected disc(s). Each patient was injected an average of 3.5 times. Overall, 43.4% of patients achieved sustained improvement as shown by average changes in numeric pain scores of 71% between pretreatment and 18-month measurements. The authors concluded that intradiscal injection of hypertonic dextrose has promise as a treatment for managing the pain of advanced lumbar disc degeneration.

Research:

In a retrospective case series of 21 patients (31) with MRI-confirmed lumbar disc degeneration and refractory low back pain/non-radicular low back pain, 18 (86%) of patients experienced 70% or greater improvements in pain and function at 1-year follow up. Patients underwent 3 Prolotherapy treatment sessions at 1–3 weeks apart, which included injections at the ligamento-periosteal junctions at the origin and insertion of the posterior sacroiliac ligaments, iliolumbar ligaments, facet joint capsules, and supraspinous and interspinous ligaments (all bilaterally). Injections were done under fluoroscopic guidance.

Research:

A small case series of 4 patients (32) with low back pain also proved successful in treating those with disc herniations with Prolotherapy. Patients underwent 3–9 Prolotherapy sessions to the ligaments of the low back (almost all 1 month apart) with all patients experiencing 95–100% pain relief and increase in function, including the ability to return to work.

A June 2021 study in the British Medical Bulletin (36) reviewed the available research on Prolotherapy for low back pain and suggested: “Considering the level of evidence and the quality of the studies assessed . . .Prolotherapy is an effective management modality for chronic low back pain patients in whom conservative therapies failed.”

Research:

Research from the University of Manitoba published in The Journal of Alternative and Complementary Medicine (65)  This study suggests that Prolotherapy using a variety of proliferants can be an effective treatment for low back pain from presumed ligamentous dysfunction for some patients when performed by a skilled practitioner

Sacroiliac joint-mediated pain

Research:

 

SI joint pain can be generated from extra-articular elements including ligaments and capsules.

(The SI joint pain does not necessarily have to come from the joint itself). Prolotherapy involves the injection into the area where repairing and strengthening are thought to be needed.

The application of Prolotherapy for SI joint pain consists of making injections in the periarticular and intra-articular areas to treat pain and sacral ligament laxity. Some studies reported the positive clinical outcomes of Prolotherapy for SI joint pain and even a superior effect and longer duration for relief of SI joint pain compared to the injection of a steroid into the joint..

In a study published in the British Journal of Sports Medicine, (57) doctors found positive clinical outcomes for 76% of patients treated with Prolotherapy suffering from sacroiliac joint problems.  In this study, 3 injections at 6-week intervals of a hypertonic dextrose solution were given into the dorsal interosseous ligament of the affected sacroiliac joint of each patient.

A 2010 paper published in The Journal of Alternative and Complementary Medicine (58) compared the pain relief effects of Prolotherapy to corticosteroid injection. At 15 months, 58% of the patients treated with Prolotherapy reported that more than half of their pain was relieved, which was statistically significant compared with only 10% in the corticosteroid group who reported that same level of pain relief. The researchers here concluded: “Intra-articular Prolotherapy provided significant relief of sacroiliac joint pain, and its effects lasted longer than those of steroid injections. Further studies are needed to confirm the safety of the procedure and to validate an appropriate injection protocol.”

In a December 2019 study, (59) doctors made these observations concerning Prolotherapy and Platelet Rich Plasma (PRP) Injections. Platelet Rich Plasma (PRP) Injections are considered a type of Prolotherapy when applied in a similar manner as explained above.

An earlier study in the Journal of Spine Disorders  (60) demonstrated that for patients with chronic low back pain who had failed to respond to previous conservative care Prolotherapy could be an effective treatment. Patients were randomly assigned to receive a double-blind series of 6 injections at weekly intervals of either a xylocaine/proliferant or a xylocaine/saline solution into the posterior sacroiliac and interspinous ligaments, fascia, and joint capsules of the lower back from L4 to the sacrum. Of the 39 patients assigned to the proliferant group, 30 achieved a 50% or greater reduction in both pain and disability scores at 6 months compared with 21 of 40 in the group receiving the saline solution. The proliferant group also achieved greater improvements on the visual analog, pain, and disability scales.

In a 2004 audit of conservative treatments for low back pain, patients who were diagnosed with sacroiliac pain via diagnostic block were treated either by corticosteroid injection to the sacroiliac joint or by Prolotherapy to the sacroiliac ligaments. Long-term improvement was assessed at 6 months, after which 63% of the Prolotherapy group reported a substantial drop in pain severity compared with only 33% in the corticosteroid group.

A December 2021 paper in the Journal of Back and Musculoskeletal Rehabilitation performed Prolotherapy on six hundred fifty-four patients with chronic low back pain and lumbar disc herniation at four to six-week intervals. The results were:

The Visual Analogue Scale (0-10 0 = no pain 10 = severe, unbearable pain) scores decreased from very severe pain of 7.2  to a mild to almost no pain score of 0.9 after 52 weeks of the treatment. Thirty-four patients’ treatments resulted in poor clinical results (5.2%), and 620 of the patients’ pain improved (94.8%).

Conclusion: “Prolotherapy can be regarded as a safe way of providing a meaningful improvement in pain and musculoskeletal function compared to the initial status. The diagnostic injection is an easy way to eliminate patients and may become a favorite treatment modality. 5% dextrose is a more simple and painless solution for Prolotherapy and also has a high success.”

PROLOTHERAPY FOR PATIENTS WITH LONG-TERM AND OFTEN SEVERE LOW BACK PAIN AND DISABILITY HAVING FAILED PHYSICAL THERAPY AND CHIROPRACTIC.

In research published in the journal International Musculoskeletal Medicine (66)doctors explored the use of Prolotherapy in patients who had failed to respond to conservative approaches including spinal manipulation and physiotherapy. These patients had longstanding and often severe pain and disability. Utilizing only treatments that included 3 injections over a 3 to 5 week period, they confirmed that 91% of respondents were better or not worse off after 12 months.

An April 2021 review article (9) published in the British Medical Bulletin examined previously reported studies on Prolotherapy patient outcomes in the treatment of chronic low back pain. The researchers combined data from 12 studies. The general conclusion was “Prolotherapy is an effective management modality for chronic low back pain in patients in whom conservative therapies failed.”

PROLOTHERAPY FOR FAILED BACK SURGERY SYNDROME

A July 2019 study in the European Spine Journal (10) suggested that “dextrose (Prolotherapy) is one of the regenerative methods that has gained popularity in the treatment of many musculoskeletal problems, and (the researchers)  aimed to present and evaluate the outcomes of 5% dextrose (Prolotherapy) for the treatment of failed back surgery syndrome.”

Study summary:

  • A total of 79 patients with failed back surgery syndrome, who had a minimum of 6 months of symptoms and did not respond to 3 months of conservative methods between May 2014 and March 2016, participated in the study. Prolotherapy injections were applied in posterior (back) and lateral (side) approaches. Visual Analog Scale (VAS) and Oswestry Disability Index (ODI) were used for the pre-and post-treatment evaluations. Patient satisfaction was assessed using a 5-point Likert scale by phone contact.

Results: There was a statistically significant difference between repeated VAS and ODI measurements.

Conclusions: These results may be the first step giving a lead to an undiscovered field. This treatment method should be kept in mind for failed back surgery syndrome patients before giving a decision of revision surgery. ”

Prolotherapy for Shoulder Pain

A November 2020 study in the Journal of Back and Musculoskeletal Rehabilitation (33) accessed the effectiveness of Prolotherapy in shoulder disorders. To do this the researchers evaluated existing studies to see if they could form a consensus on how effective, or not effective Prolotherapy can be.

Here are the summary learning points:

  • “Wide variation exists regarding usage patterns of Prolotherapy.”
    • Explanatory note: These variations included the number of injections given within a treatment (some of the studies these researchers assessed were a single injection treatment. Similar to the way cortisone is given. In our 28 years of experience, we never offer a single shot of Prolotherapy as “the treatment.” It is not effective. Read more you will see these researchers came to this conclusion as well.)
  • “Interestingly, amongst the prolotherapy studies evaluated in this review, the two in which significant pain relief was sustained long-term both utilized multiple injections and the three with either non-significant or non-sustained pain relief used a single injection.”
    • Explanatory note: Multiple injections at treatment is superior to a single injection at treatment. This is what we have been saying for three decades.

The researchers suggested: “Prolotherapy (appears) to be a safe treatment option with perhaps greater efficacy for shoulder pathology when provided through a series of injections using higher concentrations of dextrose.”

A June 2021 paper (34) found that hypertonic dextrose (Prolotherapy) infiltrations reduced pain in individuals with rotator cuffs in the long term. Hypertonic dextrose infiltrations could be an alternative to non-invasive treatments when no favorable results can be achieved. However, due to the small number of studies included in this meta-analysis, new studies are necessary to clarify the efficacy and safety of this intervention.

Comparing one Prolotherapy treatment vs One Cortisone Injection

A March 2021 study in the journal Advanced Biomedical Research (35) compared the effectiveness of Prolotherapy injections with corticosteroid injection in patients with rotator cuff dysfunction. The researchers concluded: “Both ultrasound-guided dextrose Prolotherapy and cortisone injections are effective in the management of rotator cuff-related shoulder pain in both short-term and long-term with neither being superior to the other. Therefore, Prolotherapy may be a safe alternative therapy instead of corticosteroid injection due to the lack of its side effects.” One item to note is that we typically do not find Prolotherapy to be a one-time treatment. We see its maximum benefit in three to six treatments.

Doctors at Taipei Medical University published a February 2022 study in the Archives of Physical Medicine and Rehabilitation (62) on the effects of Prolotherapy on pain and shoulder disability in patients with chronic supraspinatus tendinosis. The concluded Hypertonic dextrose Prolotherapy injection could provide short-term pain and disability relief in patients with chronic supraspinatus tendinosis. Ultrasound imaging at week 6 revealed changed tendon morphology.

The review of this study revealed familiar findings. Prolotherapy treatment can help BUT prolotherapy treatment will not be as successful if it is one shot one time, the initial success of pain relief and better range of motion and function can be sustained if further treatments are initiated.

Published research papers on Shoulder Disorders

  • Prolotherapy: A Non-Invasive Approach to Lesions of the Glenoid Labrum; A Non-Controlled Questionnaire Based Study
    • This paper was published in The Open Rehabilitation Journal.
    • Hauser RA, Dolan E, Orlofsky A. Prolotherapy: a non-invasive approach to lesions of the glenoid labrum; a non-controlled questionnaire-based study. The Open Rehabilitation Journal. 2013 Dec 27;6(1).[Google Scholar]
  • A Retrospective Study on Hackett-Hemwall Dextrose Prolotherapy for Chronic Shoulder Pain at an Outpatient Charity Clinic in Rural Illinois
    • This paper was published in the Journal of Prolotherapy.
    • Hauser RA, Hauser MA. A retrospective study on Hackett-Hemwall dextrose Prolotherapy for chronic shoulder pain at an outpatient charity clinic in rural Illinois. J Prolotherapy. 2009;4:205-16. [Google Scholar]

 

Demonstration of a typical shoulder treatment for recurrent shoulder dislocation and rotator cuff instability.

The patient complained of shoulder instability typical of the ligament and tendon damage multiple dislocations can do.

With the patient sitting, treatment continues to the anterior or front of the shoulder. The rotator cuff insertions, the anterior joint capsule, and the glenohumeral ligaments are treated.

PRP is introduced into the treatment and injected into the front of the shoulder. PRP is a form of Prolotherapy where we take concentrated cells and platelets from the patient’s blood and inject that back into the joint. It is a more aggressive form of Prolotherapy and we typically use it for someone that has had a labral tear, shoulder osteoarthritis, and cartilage lesions.

Prolotherapy for Cervical Spine Instability and related symptoms

This section will also provide information on the following symptoms as they relate to neck pain and cervical spine instability

  • Headache and Migraine
  • TMJ
  • Whiplash Associated Disorder
  • Hearing problems
  • Vision problems
  • Swallowing difficulties
  • Dizziness
  • Drop Attacks
  • Vagus Nerve disorders

The Horrific Progression of Neck Degeneration with Unresolved Cervical Instability. Cervical instability is a progressive disorder causing a normal lordotic curve to end up as an “S” or “Snake” curve with crippling degeneration.
The Horrific Progression of Neck Degeneration with Unresolved Cervical Instability. Cervical instability is a progressive disorder causing a normal lordotic curve to end up as an “S” or “Snake” curve with crippling degeneration..

Published research papers  on Cervical Spine Instability and related symptoms

Degenerative Disc Disease in the Cervical Spine

Prolotherapy and Whiplash Associated Disorders

A September 2020 study in the journal Regenerative Medicine (44) presented successful treatment of severe, longstanding, treatment-resistant Whiplash-Associated Disorders with Prolotherapy.

  • The chronic whiplash-associated disorder can develop after flexion/extension injuries and may be refractory (difficult or non-responsive) to standard-of-care therapies.

Learning points

  • Four monthly sessions of fluoroscopically guided Prolotherapy with phenol (an organic compound typically given in cases of spasticity)-glycerin-glucose.
  • Results: Significant improvement was achieved in pain, disability, pain interference, depression, anxiety, sleep, and quality of life and maintained through 18 months after treatment in all assessed pain and functional measures.

Patient outcomes and case histories following Prolotherapy injections for whiplash have a decades-long history. George Hackett MD, a pioneer in the treatment of Prolotherapy published findings in 1960 (45) and 1962 (46). In these papers, Dr. Hackett and his colleagues reported treating patients with whiplash injuries and noted more than 85% of patients had cervical ligament injury-related symptoms, including those with headache or whiplash associated disorder These patients upon completion of treatment reported they had minor to no residual pain or related symptoms after Prolotherapy. In a 1963 study published in the medical journal Headache (47) Dr. Hackett was a co-author on this paper led by Daniel Kayfetz DO. In this study, 206 patients were treated with Prolotherapy for their whiplash-related headaches. Outcome results showed that in 79% of patients, prolotherapy completely relieved their headaches.

This is also confirmed in our own published research spearheaded by Danielle R. Steilen-Matias, PA-C. In this research that appeared in The Open Orthopaedics Journalwe showed that conventional treatments for chronic neck pain remain debatable, primarily because most treatments have had limited success because they did not address the cervical ligaments. In our study, we were able to conclude and document Prolotherapy injections to be an effective treatment for chronic neck pain and cervical instability due to whiplash, especially when due to ligament laxity in the cervical joints. (48)

Prolotherapy for hip pain


Published research papers  on Hip Disorders

In the Journal of Prolotherapy, we sought to show how Prolotherapy could provide high levels of patient outcome satisfaction while avoiding hip surgery. Here is what we reported:

  • We examined Sixty-one patients, representing 94 hips, who had been in pain an average of 63 months We treated these patients quarterly with Hackett-Hemwall dextrose Prolotherapy.
  • This included a subset of 20 patients who were told by their medical doctor(s) that there were no other treatment options for their pain and a subset of eight patients who were told by their doctor(s) that surgery was their only option.

Patients have contacted an average of 19 months following their last Prolotherapy session and asked questions regarding their levels of pain, physical and psychological symptoms, and activities of daily living, before and after their last Prolotherapy treatment.

Results: In these 94 hips,

  • pain levels decreased from 7.0 to 2.4 after Prolotherapy;
  • 89% experienced more than 50% of pain relief with Prolotherapy;
  • more than 84% showed improvements in walking and exercise ability, anxiety, depression, and overall disability;
  • 54% were able to completely stop taking pain medications.

The results confirm that Prolotherapy is a treatment that should be highly considered for people suffering from chronic hip pain.

Published research on Prolotherapy:

Dr. Ross Hauser and our team have published a number of research papers, case studies, and scientific editorials in the Journal of Prolotherapy, including articles on Prolotherapy as an alternative to surgery; Prolotherapy for chronic back pain; cartilage regeneration in knees; Stem cell therapy for degenerative joint disease; Prolotherapy as for meniscus tears, and many, many more.

Dysplasia of the hip

A February 2020 study  (56) looked at patients who developed osteoarthritis as a result of developmental dysplasia of the hip, (the socket of the hip joint being too shallow) and treated some patients with Prolotherapy and others with an exercise program.

  • There were 46 hips of 41 patients who had osteoarthritis secondary to developmental dysplasia of the hip included in this study.
  • Patients were divided into 2 groups:
    • 20 treated with Prolotherapy and
    • 21 treated with exercise.
    • Clinical outcomes were evaluated with a visual analog scale for pain (VAS) and Harris hip score (HHS) at baseline, 3 weeks, 3 months, 6 months, and a minimum of 1-year follow-up.
  • Dextrose Prolotherapy injection recipients outperformed exercise controls for visual analog scale for pain (VAS) change score at 6 months and 12 months and for Harris hip score function scores at 6 months and 12 months.

The study concluded: “Prolotherapy could provide significant improvement for clinical outcomes in developmental dysplasia of the hip and might delay surgery.

Prolotherapy for Medial tibial stress syndrome – shin splints

A study published in the Journal of Foot and Ankle Research (37) examined the effectiveness of Prolotherapy injections in difficult to treat and chronic Medial tibial stress syndrome. In this study sports active people were treated and followed to see how many returned to sports and at what level.

Conclusions: “Ultrasound-guided 15% dextrose Prolotherapy injection has a significant medium-term effect on pain in Medial tibial stress syndrome. This benefit may be maintained long-term; however, more robust trials are required to validate these findings. . . Clinicians should consider the use of ultrasound-guided injection of 15% dextrose as a viable treatment option to reduce pain and aid return to activity for patients with recalcitrant Medial tibial stress syndrome.”

More research on possible patient outcomes using Prolotherapy for shin splints can be found here: When you have chronic and painful shin splints and nothing helped

Adductor-related groin pain syndrome

A March 2021 review study (38) looked at research outcomes for the treatment of Adductor-related groin pain. They found that the intervention(s) showing the greater level of strength of evidence, and the greater grade of recommendation are compression clothing therapy, manual therapy and strengthening exercise, and prolotherapy.”

Prolotherapy for TMJ related pain

The research on Prolotherapy for Temporomandibular Joint Pain and Dysfunction


Prolotherapy for TMJ. 

In this section, we will discuss how to turn a degenerative TMJ environment into a healing environment through the use of Comprehensive Prolotherapy.

“Dextrose prolotherapy is one of the most promising approaches in the management of TMD”

A March 2021 study in the Journal of Maxillofacial and Oral Surgery (11) writes: (This) study concluded that Prolotherapy is an effective therapeutic modality that reduces TMJ pain, improves joint stability and range of motion in a majority of patients. It can be a first-line treatment option as it is safe, economical and an easy procedure associated with minimal morbidity.”

In March 2019, publishing in the journal Mayo Clinic Proceedings (12)  doctors from the University of British Columbia, University of Missouri-Kansas City, School of Medicine, the University of Wisconsin School of Medicine and Public Health, and the Chinese University of Hong Kong announced these findings in their study to assess the LONG-TERM effectiveness of dextrose Prolotherapy injections in study participants with temporomandibular dysfunction. Their results: “Intraarticular (Prolotherapy) resulted in clinically important and statistically significant improvement in pain and dysfunction at 12 months compared to lidocaine injection.”

Indian doctors writing in the Journal of Maxillofacial and Oral Surgery (13found positive results utilizing Prolotherapy injections for TMJ in recent research (June 2017). Here is what they said: In their study, the researchers examined 23 patients suffering from either chronic recurrent dislocation or subluxation of the TMJ who were treated with the single-injection technique Prolotherapy with 25 % dextrose into the pericapsular tissues along with auriculotemporal nerve block.

  • The overall success rate in the study was 91.3 % (21/23) with a minimum follow-up period of 13.9 months.
  • The number of successfully treated patients requiring one injection was 7 (30.4 %), two injections were 8 (34.7 %), and requiring three injections was 6 (26.1 %). There were no permanent complications.

Prolotherapy reports on TMJ disc dislocation

In Prolotherapy research, doctors say that they see appreciable improvements in the number of episodes of dislocation and clicking after Prolotherapy treatment.

  • Doctors writing in the British Journal of Oral and Maxillofacial Surgery found that Prolotherapy injections were curative in preventing recurrent TMJ dislocations. In fact, nearly 2 of 3 of these patients achieved this result with a single treatment. (14)

Prolotherapy and aspiration (arthrocentesis) provided significant relief for TMJ patients.

Doctors at Ordu University in Turkey published in The Journal of Alternative and Complementary Medicine (15) suggesting that Prolotherapy and aspiration (Arthrocentesis) provided significant relief for TMJ patients.

A December 2020 study in the medical journal Cranio, Journal of Craniomandibular Practice (16) also compared the effectiveness of dextrose Prolotherapy in conjunction with arthrocentesis (fluid draining of the TMJ) and dextrose prolotherapy alone in the management of symptomatic TMJ hypermobility. The study concluded Prolotherapy is effective in the management of TMJ hypermobility. However, Prolotherapy with arthrocentesis may be superior to Prolotherapy alone in the management of TMJ hypermobility.

March 2021 paper in the journal Head and Face Medicine (39) examined and treated Forty adolescents and young adults, aged 16 to 30 years old, with distinct combination of symptoms of TMJ “closed lock.” Patients received anesthetic blockages of the auriculotemporal nerve, then performed mandibular condylar movement exercise for 10 min, and subsequently received hypertonic dextrose Prolotherapy in retro-discal area of TMJ. Clinical assessments at baseline and at follow-up (2 weeks, 2 months, 6 months, and 5 years) included intensity and frequency of TMJ pain, mandibular range of motion, TMJ sounds, and impairment of chewing. Conclusions: “The technique combining mandibular condylar movement exercise with an auriculotemporal nerve block and dextrose Prolotherapy is straightforward to perform, inexpensive and satisfactory to young patients with TMJ closed lock.”

A July 2018 paper in the Journal of Oral Rehabilitation compared Prolotherapy to Placebo injections. The researchers found: “Within the limitations of the study, dextrose Prolotherapy may cause significant reduction in mouth opening and pain associated with TMJ hypermobility. Conclusions with regard to the reduction of episodes of subluxation/dislocation cannot be drawn. ” In their study that could not give good evidence that TMJ subluxations or dislocations were reduced. (43)

A February 2022 paper in the journal Oral and Maxillofacial Surgery Clinics of North America (63) found “Prolotherapy with hypertonic glucose is effective for treating hypermobility and subluxation of the temporomandibular joint.”

Prolotherapy for Elbow Pain

Research: Prolotherapy superior to cortisone injections

A November 2019 study in the journal Orthopedic Research and Reviews (41) compared the effectiveness of Prolotherapy to corticosteroid injections. “This investigation showed that both corticosteroid injection and dextrose Prolotherapy efficiently improved pain and function in patients with chronic lateral epicondylitis. In the Prolotherapy group, this improvement persisted even after 1-month follow-up and the results after one injection were still improvable, whereas, in the parallel-group, steroids only provided a short-term improvement. This finding proved that dextrose Prolotherapy had better and longer effects in treating chronic tennis elbow.”

Prolotherapy compared to Hyaluronic acid injection

September 2020 study in The Journal of Alternative and Complementary Medicine, (42) compared the effects of hyaluronic acid and dextrose Prolotherapy injections in patients with chronic lateral epicondylalgia. Hyaluronic acid injection and Prolotherapy injections were both effective in reducing pain and increasing grip strength and function in patients with chronic lateral epicondylalgia. Prolotherapy injection was more effective in the short term than Hyaluronic acid injection, in terms of pain relief and functional outcome.

A January 2022 paper (50) published in the journal Arthroscopy found “Dextrose Prolotherapy and extracorporeal shock wave therapy (ESWT) were the best two treatment options for pain control and extracorporeal shock wave therapy was the best treatment option for grip strength recovery. Corticosteroids were not recommended for the treatment of lateral epicondylitis. More evidence is required to confirm the superiority in pain control of Dextrose Prolotherapy among all these treatment options on lateral epicondylitis.”

  • In the Clinical Journal of Sports Medicine, doctors found that their Prolotherapy treatment group showed significant improvement in pain levels compared with patients given a saline injection with the same number of needle punctures and volume (91% versus 33%). In addition, extension strength and grip strength were markedly improved in the treatment group as well. (51)
  • In another study, researchers achieved a significant reduction in pain  in lateral epicondylosis as well with the treatment of the lateral epicondyle with 15% dextrose. Evidence of tendon healing was observed via ultrasound imaging. (52)
  • A September 2020 study in the Journal of Alternative and Complementary Medicine (53) found that dextrose Prolotherapy offered significant benefits as compared to saline injections in function and pain scores.

Prolotherapy for chronic plantar fasciitis

  • Comparing Prolotherapy to cortisone for chronic plantar fasciitis
  • Comparing Prolotherapy to extracorporeal shockwave therapy (ESWT).

A study from 2021 published in the journal Foot and Ankle Specialist (40) compared one injection of cortisone and one injection of dextrose.

  • A total of 44 patients suffering from chronic plantar fasciitis were included.
  • Two table-randomized groups were formed. They received an ultrasonography-guided, single injection of either 40 mg methylprednisolone or 20% dextrose.
  • Both interventions significantly improved pain and function at 2 and 12 weeks post-injection.
  • Conclusion: Both methods are effective. Compared with dextrose Prolotherapy, our results show that corticosteroid injection may have superior therapeutic effects early after injection, accompanied by a similar outcome at 12 weeks post-injection. One injection of dextrose was just as good as one injection of cortisone by 12 weeks.

A February 2022 study in The Journal of Foot and Ankle Surgery (64) compared the effectiveness of extracorporeal shockwave therapy (ESWT) versus dextrose Prolotherapy on pain and foot functions in patients with chronic plantar fasciitis.

  • A total of 29 patients were randomly assigned to receive ESWT (15 patients) or dextrose Prolotherapy (14 patients).
  • ESWT group received 3 treatment2.
  • The dextrose Prolotherapy group underwent an injection of 5 ml 15% dextrose solution with 2% lidocaine. (Our note: One injection of dextrose is one injection of dextrose we do not consider it a Prolotherapy treatment).

Results of three ESWT sessions versus three single injections of dextrose:

  • ESWT and dextrose Prolotherapy were repeated 3 times by 2 weeks apart.
  • Symptoms such as morning pain, foot function improved significantly in both treatment groups at 6 weeks and 12 weeks compared to baseline.
  • In (this) study dextrose Prolotherapy and ESWT had similar effectiveness in patients with chronic plantar fasciitis who have not responded to conservative care.

Prolotherapy for myofascial pain syndrome

A September 2020 study (55) evaluated the effectiveness of targeted ultrasound-guided dextrose injection for localized myofascial pain syndrome. In this study, 45 patients with myofascial pain syndrome were non-responsive to alternative treatments with targeted ultrasound-guided dextrose injection. Pretreatment symptom severity and symptomatic response 1 month after treatment were statistically analyzed using a visual analog scale (VAS)-based scoring system.

  • Of 45 patients, 8 (24.4%) reported complete resolution of symptoms at the treated site.
  • In total, 36 (80.0%) patients reported greater than 50% improvement in their symptoms.
  • Scoring indicated that patients achieved on average an overall 65.0% reduction in symptom severity.

Conclusion: Targeted ultrasound-guided dextrose injection was remarkably effective for refractory localized myofascial pain syndrome, significantly reducing symptom intensities in the majority of treated patients within one month after a single injection.

Our Prolotherapy research papers, case studies, & scientific editorials:


Prolotherapy Side effects and risks

  • Bleeding in the area
  • Bruising in the area
  • Increased pain
  • Infection
  • Joint effusion
  • Nerve injury
  • Puncture of a lung
  • Spinal headache
  • Stiffness
  • Swelling
  • Tendon/ligament injury

Because Prolotherapy causes inflammation, the person will often note some bruising, pain, stiffness and swelling in the area after receiving Prolotherapy. Typically this lasts 1 to 7 days. On rare occasions, it lasts longer. Lasting longer is not necessarily bad, some people just inflame more easily. Since the treatment works by inflammation, lingering pain after Prolotherapy can be a sign of healing. If the pain is severe after Prolotherapy, then call the office where the Prolotherapy was done. Prolotherapy should not cause excessive, severe pain. Severe pain after Prolotherapy, especially accompanied by a fever, could indicate an infection. Infection after Prolotherapy is the most serious risk that we have seen.

The risk of infection after Prolotherapy is between 1 and 1000 to 1 and 10,000 procedures. The most common infection with Prolotherapy is an infection in the skin. This type of infection typically responds to an antibiotic taken by mouth. If a joint or blood infection results, then intravenous antibiotics will typically be needed for six weeks.

Since some of the risks with Prolotherapy relate to the actual technique or solutions used, it is important to go to a clinic with a lot of experience and one who has researched the best options for various types of pain, versus just utilizing the same ingredients for every patient.

References

1 Bae G, Kim S, Lee S, Lee WY, Lim Y. Prolotherapy for the patients with chronic musculoskeletal pain: systematic review and meta-analysis. Anesthesia and Pain Medicine. 2020 Dec 16. [Google Scholar]
2 Bae G, Kim S, Lee S, Lee WY, Lim Y. Prolotherapy for the patients with chronic musculoskeletal pain: systematic review and meta-analysis. Anesthesia and Pain Medicine. 2021 Jan 31;16(1):81. [Google Scholar]
3 Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. A Systematic Review of Dextrose Prolotherapy for Chronic Musculoskeletal Pain. Clinical Medicine Insights Arthritis and Musculoskeletal Disorders. [Google Scholar]
4 Johnston E, Kou Y, Junge J, Chen L, Kochan A, Johnston M, Rabago D. Hypertonic Dextrose Stimulates Chondrogenic Cells to Deposit Collagen and Proliferate. Cartilage. 2021 Jun 10:19476035211014572. [Google Scholar]
5 Shan Sit RW, Keung Wu RW, Rabago D, et al. Efficacy of Intra-Articular Hypertonic Dextrose (Prolotherapy) for Knee Osteoarthritis: A Randomized Controlled Trial. Ann Fam Med. 2020;18(3):235‐242. doi:10.1370/afm.2520 [Google Scholar]
6 Sert AT, Sen EI, Esmaeilzadeh S, Ozcan E. The Effects of Dextrose Prolotherapy in Symptomatic Knee Osteoarthritis: A Randomized Controlled Study. J Altern Complement Med. 2020;26(5):409‐417. doi:10.1089/acm.2019.0335 [Google Scholar]
7 Rabago D, Kansariwala I, Marshall D, Nourani B, Stiffler-Joachim M, Heiderscheit B. Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis: Feasibility, Acceptability, and Patient-Oriented Outcomes in a Pilot-Level Quality Improvement Project. The Journal of Alternative and Complementary Medicine. 2019 Jan 28. [Google Scholar]
8 Wee TC, Neo EJ, Tan YL. Dextrose prolotherapy in knee osteoarthritis: A systematic review and meta-analysis. Journal of Clinical Orthopaedics and Trauma. 2021 May 20. [Google Scholar]
9 Giordano L, Murrell WD, Maffulli N. Prolotherapy for chronic low back pain: a review of literature. Br Med Bull. 2021 Apr 21:ldab004. doi: 10.1093/bmb/ldab004. Epub ahead of print. PMID: 33884404. [Google Scholar]
10 Solmaz İ, Akpancar S, Örsçelik A, Yener-Karasimav Ö, Gül D. Dextrose injections for failed back surgery syndrome: a consecutive case series. European Spine Journal. 2019 Jul;28(7):1610-7. [Google Scholar]
11 Dasukil S, Arora G, Shetty SK, Degala S. Impact of Prolotherapy in TMDs: a quality of life assessment. British Journal of Oral and Maxillofacial Surgery. 2020 Oct 27. [Google Scholar]
12 Louw WF, Reeves KD, Lam SK, Cheng AL, Rabago D. Treatment of temporomandibular dysfunction with hypertonic dextrose injection (prolotherapy): A randomized controlled trial with long-term partial crossover. InMayo Clinic Proceedings 2019 May 1 (Vol. 94, No. 5, pp. 820-832). Elsevier. [Google Scholar]
13 Majumdar SK, Krishna S, Chatterjee A, Chakraborty R, Ansari N. Single Injection Technique Prolotherapy for Hypermobility Disorders of TMJ Using 25 % Dextrose: A Clinical Study. J Maxillofac Oral Surg. 2017 Jun;16(2):226-230. [Google Scholar]
14  Zhou H, Hu K, Ding Y. Modified dextrose prolotherapy for recurrent temporomandibular joint dislocation. Br J Oral Maxillofac Surg. 2014 Jan;52(1):63-6. doi: 10.1016/j.bjoms.2013.08.018. [Google Scholar]
15 Cezairli B, Sivrikaya EC, Omezli MM, Ayranci F, Cezairli NS. Results of Combined, Single-Session Arthrocentesis and Dextrose Prolotherapy for Symptomatic Temporomandibular Joint Syndrome: A Case Series. The Journal of Alternative and Complementary Medicine. 2017 Oct 10. [Google Scholar]
16 Taşkesen F, Cezairli B. Efficacy of prolotherapy and arthrocentesis in management of temporomandibular joint hypermobility. CRANIO®. 2020 Dec 18:1-9. [Google Scholar]
17 Kuo HC, Pan PJ, Wang JC, Tsai CC. Identification of early response to hypertonic dextrose prolotherapy markers in knee osteoarthritis patients by an inflammation-related cytokine array. [Google Scholar]
18 Arias-Vázquez PI, Tovilla-Zárate CA, Castillo-Avila RG, Legorreta-Ramírez BG, López-Narváez ML, Arcila-Novelo R, González-Castro TB. Hypertonic Dextrose Prolotherapy, an alternative to intra-articular injections with Hyaluronic Acid in the treatment of knee osteoarthritis: systematic review and meta-analysis. American Journal of Physical Medicine & Rehabilitation. 2021 Nov 3. [Google Scholar]
19 Wu Z, Tu X, Tu Z. Hyperosmolar dextrose injection for Osgood–Schlatter disease: a double-blind, randomized controlled trial. Archives of Orthopaedic and Trauma Surgery. 2021 Oct 21:1-7. [Google Scholar]
20 Wang J, Liang J, Yao J, Song HX, Yang XT, Wu FC, Ye Y, Li JH, Wu T. Meta-analysis of clinical trials focusing on hypertonic dextrose prolotherapy (HDP) for knee osteoarthritis. Aging clinical and experimental research. 2021 Aug 27:1-0. [Google Scholar]
21 Ashraf A, Hosseini SS. The Efficacy of Ozone Prolotherapy Compared to Intra-Articular Hypertonic Saline Injection in Reducing Pain and Improving the Function of Patients with Knee Osteoarthritis: A Randomized Clinical Trial. Evidence-Based Complementary and Alternative Medicine. 2021 Aug 3;2021. [Google Scholar]
22 Imani F, Hejazian K, Kazemi MR, Narimani-Zamanabadi M, Malik KM. Adding Ozone to Dextrose and Somatropin for Intra-articular Knee Prolotherapy: A Randomized Single-Blinded Controlled Trial. Anesthesiology and Pain Medicine. 2020 Oct;10(5). [Google Scholar]
23 Johnston E, Kou Y, Junge J, Chen L, Kochan A, Johnston M, Rabago D. Hypertonic Dextrose Stimulates Chondrogenic Cells to Deposit Collagen and Proliferate. Cartilage. 2021 Jun 10:19476035211014572. [Google Scholar]
24 Wee TC, Neo EJ, Tan YL. Dextrose prolotherapy in knee osteoarthritis: A systematic review and meta-analysis. Journal of Clinical Orthopaedics and Trauma. 2021 May 20. [Google Scholar]
25 WALUYO M, BUDU M, BUDU M, BUKHARI M, ADNAN M, HARYADI D, IDRIS M, HAMID M, USMAN M, JOHAN P, ZAINUDDIN A. Changes in levels of cartilage oligomeric proteinase and urinary C-terminal telopeptide of type II collagen in subjects with knee osteoarthritis after dextrose prolotherapy: A randomized controlled trial. J Rehabil Med. 2021. [Google Scholar]
26 Rahimzadeh P, Imani F, Faiz SH, Entezary SR, Zamanabadi MN, Alebouyeh MR. The effects of injecting intra-articular platelet-rich plasma or prolotherapy on pain score and function in knee osteoarthritis. Clinical interventions in aging. 2018;13:73. [Google Scholar]
27 Sert AT, Sen EI, Esmaeilzadeh S, Ozcan E. The effects of dextrose prolotherapy in symptomatic knee osteoarthritis: a randomized controlled study. The Journal of Alternative and Complementary Medicine. 2020 May 1;26(5):409-17. [Google Scholar]
28 Arias-Vázquez, P.I., Tovilla-Zárate, C.A., Legorreta-Ramírez, B.G., Fonz, W.B., Magaña-Ricardez, D., González-Castro, T.B., Juárez-Rojop, I.E. and López-Narváez, M.L., 2019. Prolotherapy for knee osteoarthritis using hypertonic dextrose vs other interventional treatments: systematic review of clinical trials. Advances in Rheumatology59. [Google Scholar]
29 Hauser RA, Matias D, Woznica D, Rawlings B, Woldin BA. Lumbar instability as an etiology of low back pain and its treatment by prolotherapy: A review. Journal of Back and Musculoskeletal Rehabilitation. 2021 Dec 14(Preprint):1-2. [Google Scholar]
30 Wilkinson HA. Injection therapy for enthesopathies causing axial spine pain and the “failed back syndrome”: a single blinded, randomized and cross-over study. Pain physician. 2005 Apr;8(2):167-73. [Google Scholar]
31 Inklebarger J, Petrides S, Prolotherapy for Lumbar Segmental Instability Associated with Degenerative Disc Disease. Journal of Prolotherapy. 2016;8:e971-e977. [Google Scholar]
32 Alderman D. Prolotherapy for low back pain. Practical Pain Management. 2007;7(4):58-63. [Google Scholar]
33. Robinson DM, Eng C, Makovitch S, Rothenberg JB, DeLuca S, Douglas S, Civitarese D, Borg-Stein J. Non-operative orthobiologic use for rotator cuff disorders and glenohumeral osteoarthritis: A systematic review. Journal of Back and Musculoskeletal Rehabilitation. 2021 Jan 1;34(1):17-32. [Google Scholar]
34 PI AV, CA TZ, TB GC, ML LN, RG CA. Efficacy of hypertonic dextrose infiltrations for pain control in rotator cuff tendinopathy: systematic review and meta-analysis. Acta Reumatológica Portuguesa. 2021 Apr 1;46(2). [Google Scholar]
35 Nasiri A, Jahromi LS, Vafaei MA, Parvin R, Fakheri MS, Sadeghi S. Comparison of the effectiveness of ultrasound-guided prolotherapy in supraspinatus tendon with ultrasound-guided corticosteroid injection of subacromial subdeltoid bursa in rotator cuff-related shoulder pain: A clinical trial study. Advanced Biomedical Research. 2021 Jan 1;10(1):12. [Google Scholar]
36 Giordano L, Murrell WD, Maffulli N. Prolotherapy for chronic low back pain: a review of literature. British Medical Bulletin. 2021 Apr 21. [Google Scholar]
37 Padhiar N, Curtin M, Aweid O, Aweid B, Morrissey D, Chan O, Malliaras P, Crisp T. The effectiveness of PROLOTHERAPY for recalcitrant Medial TIBIAL Stress Syndrome: a prospective consecutive CASE series. Journal of Foot and Ankle Research. 2021 Dec;14(1):1-2. [Google Scholar]
38 Bisciotti GN, Chamari K, Cena E, Rodriguez Garcia G, Vuckovic Z, Bisciotti A, Bisciotti A, Zini R, Corsini A, Volpi P. The conservative treatment of longstanding adductor-related groin pain syndrome: a critical and systematic review. Biology of Sport. 2021;38(1). [Google Scholar]
39 Zhou H, Xue Y, Liu P. Application of auriculotemporal nerve block and dextrose prolotherapy in exercise therapy of TMJ closed lock in adolescents and young adults. Head & Face Medicine. 2021 Dec;17(1):1-7. [Google Scholar]
40 Raissi G, Arbabi A, Rafiei M, Forogh B, Babaei-Ghazani A, Khalifeh Soltani S, Ahadi T. Ultrasound-Guided Injection of Dextrose Versus Corticosteroid in Chronic Plantar Fasciitis Management: A Randomized, Double-Blind Clinical Trial. Foot Ankle Spec. 2021 Jan 19:1938640020980924. doi: 10.1177/1938640020980924. Epub ahead of print. PMID: 33461323. [Google Scholar]
41 Bayat M, Raeissadat SA, Babaki MM, Rahimi-Dehgolan S. Is Dextrose Prolotherapy Superior To Corticosteroid Injection In Patients With Chronic Lateral Epicondylitis?: A Randomized Clinical Trial. Orthopedic Research and Reviews. 2019;11:167. [Google Scholar]
42 Apaydin H, Bazancir Z, Altay Z. Injection Therapy in Patients with Lateral Epicondylalgia: Hyaluronic Acid or Dextrose Prolotherapy? A Single-Blind, Randomized Clinical Trial [published online ahead of print, 2020 Sep 15]. J Altern Complement Med. 2020;10.1089/acm.2020.0188. doi:10.1089/acm.2020.0188 [Google Scholar]
43 Nagori SA, Jose A, Gopalakrishnan V, Roy ID, Chattopadhyay PK, Roychoudhury A. The efficacy of dextrose prolotherapy over placebo for temporomandibular joint hypermobility: A systematic review and meta‐analysis. Journal of oral rehabilitation. 2018 Jul 19. [Google Scholar]
44 Stogicza AR, Guo MYF, Rabago D. Whiplash injury successfully treated with prolotherapy: a case report with long-term follow up. Regen Med. 2020 Dec 1. doi: 10.2217/rme-2020-0063. Epub ahead of print. PMID: 33259262. [Google Scholar]
45 Hackett GS. Prolotherapy in whiplash and low back pain. Postgraduate Medicine. 1960 Feb 1;27(2):214-9. [Google Scholar]
46 Hackett GS, Huang TC, Raftery A. Prolotherapy for headache. Pain in the head and neck, and neuritis. Headache 1962;2:20-8. [Google Scholar]
47 Kayfetz DO, Blumenthal LS, Hackett GS, Hemwall GA, Neff FE. Whiplash injury and other ligamentous headache–its management with prolotherapy. Headache 1963;3:21-8. [Google Scholar]
48 Steilen D, Hauser R, Woldin B, Sawyer S. Chronic Neck Pain: Making the Connection Between Capsular Ligament Laxity and Cervical Instability. The Open Orthopaedics Journal. 2014;8:326-345. [Google Scholar]
49 Morath O, Beck M, Taeymans J, Hirschmüller A. Sclerotherapy and prolotherapy for chronic patellar tendinopathies – a promising therapy with limited available evidence, a systematic review. J Exp Orthop. 2020 Nov 9;7(1):89. doi: 10.1186/s40634-020-00303-0. PMID: 33165667. [Google Scholar]
50 Liu WC, Chen CT, Lu CC, Tsai YC, Liu YC, Hsu CW, Shih CL, Chen PC, Fu YC. Extracorporeal Shock Wave Therapy shows Superiority over Injections for Pain Relief and Grip Strength Recovery in Lateral Epicondylitis: A Systematic Review and Network Meta-Analysis. Arthroscopy. 2022 Jan 27:S0749-8063(22)00028-7. doi: 10.1016/j.arthro.2022.01.025. Epub ahead of print. PMID: 35093494.
51 Scarpone M, Rabago DP, Zgierska A, Arbogast G, Snell E. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin J Sport Med. 2008;18(3):248–54. [Google Scholar]
52 Park JH, Song IS, Lee JB, et al. Ultrasonographic findings of healing of torn tendon in the patients with lateral epicondylitis after prolotherapy. J Korean Soc Med Ultrasound. 2003;22(3):177–83. [Google Scholar]
53 Akcay S, Gurel Kandemir N, Kaya T, Dogan N, Eren M. Dextrose Prolotherapy Versus Normal Saline Injection for the Treatment of Lateral Epicondylopathy: A Randomized Controlled Trial. The Journal of Alternative and Complementary Medicine. 2020 Sep 28. [Google Scholar]
54 Rezasoltani Z, Taheri M, Mofrad MK, Mohajerani SA. Periarticular dextrose prolotherapy instead of intra-articular injection for pain and functional improvement in knee osteoarthritis. Journal of Pain Research. 2017;10:1179-1187.  [Google Scholar]
55 Chou Y, Chiou HJ, Wang HK, Lai YC. Ultrasound-guided dextrose injection treatment for chronic myofascial pain syndrome: A retrospective case series. Journal of the Chinese Medical Association. 2020 Sep;83(9):876. [Google Scholar]
56 Gül D, Orsçelik A, Akpancar S. Treatment of Osteoarthritis Secondary to Developmental Dysplasia of the Hip with Prolotherapy Injection versus a Supervised Progressive Exercise Control. Med Sci Monit. 2020;26:e919166. Published 2020 Feb 11. doi:10.12659/MSM.919166 [Google Scholar]
57 Cusi M, Saunders J, Hungerford B, Wisbey-Roth T, Lucas P, Wilson S. The use of prolotherapy in the sacroiliac joint. British journal of sports medicine. 2010 Feb 1;44(2):100-4. [Google Scholar]
58 Kim WM, Lee HG, Won Jeong C, Kim CM, Yoon MH. A randomized controlled trial of intra-articular prolotherapy versus steroid injection for sacroiliac joint pain. The journal of alternative and complementary medicine. 2010 Dec 1;16(12):1285-90. [Google Scholar]
59 Chuang CW, Hung SK, Pan PT, Kao MC. Diagnosis and interventional pain management options for sacroiliac joint pain. Ci Ji Yi Xue Za Zhi. 2019 Sep 16;31(4):207-210. [Google Scholar]
60 Klein RG, Eek BC, DeLong WB, Mooney V. A randomized double-blind trial of dextrose-glycerine-phenol injections for chronic, low back pain. Journal of Spinal Disorders. 1993 Feb 1;6(1):23-33. [Google Scholar]
61 Eslamian F, Amouzandeh B. Therapeutic effects of prolotherapy with intra-articular dextrose injection in patients with moderate knee osteoarthritis: a single-arm study with 6 months follow up. Ther Adv Musculoskelet Dis. 2015 Apr;7(2):35-44. [Google Scholar]
62 Lin CL, Chen YW, Wu CW, Liou TH, Huang SW. Effect of Hypertonic Dextrose Injection on Pain and Shoulder Disability in Patients with Chronic Supraspinatus Tendinosis: A Randomized Double-Blind Controlled Study. Archives of Physical Medicine and Rehabilitation. 2021 Oct 2. [Google Scholar]
63 Andre A, Kang J, Dym H. Pharmacologic Treatment for Temporomandibular and  Temporomandibular Joint Disorders. Oral and Maxillofacial Surgery Clinics. 2022 Feb 1;34(1):49-59. [Google Scholar]
64 Kesikburun S, Şan AU, Kesikburun B, Aras B, Yaşar E, Tan AK. Comparison of Ultrasound-Guided Prolotherapy Versus Extracorporeal Shock Wave Therapy in the Treatment of Chronic Plantar Fasciitis: A Randomized Clinical Trial. The Journal of Foot and Ankle Surgery. 2022 Jan 1;61(1):48-52. [Google Scholar]
65 Watson JD, Shay BL. Treatment of chronic low-back pain: a 1-year or greater follow-up. J Altern Complement Med. 2010 Sep;16(9):951-8. doi: 10.1089/acm.2009.0719. [Google Scholar]
66 Jacks A, Barling T. Lumbosacral prolotherapy: a before-and-after study in an NHS setting. International Musculoskeletal Medicine. 2012 Apr 1;34(1):7-12.  [Google Scholar]
67 Schroeder A, Onishi K. Vague Posterior Knee Discomfort in a Soccer Player: A Clinical Vignette. American Journal of Physical Medicine & Rehabilitation. 2020 Apr 1;99(4):e46-9. [Google Scholar]
68 Grote W, Delucia R, Waxman R, Zgierska A, Wilson J, Rabago D. Repair of a complete anterior cruciate tear using prolotherapy: a case report.Int Musculoskelet Med. 2009 Dec 1;31(4):159-165 [Google Scholar]
69 Reeves KD Hassanein K Long term effects of dextrose prolotherapy for anterior cruciate ligament laxity: A prospective and consecutive patient study. Alt Ther Hlth Med May-Jun 2003, 9(3): p58-62.[Google Scholar]
70 Chen YW, Lin YN, Chen HC, Liou TH, Liao CD, Huang SW. Effectiveness, Compliance, and Safety of Dextrose Prolotherapy for Knee Osteoarthritis: A Meta-Analysis and Metaregression of Randomized Controlled Trials. Clinical Rehabilitation. 2022 Mar 8:02692155221086213. [Google Scholar]